Researchers have developed an implantable therapy using leptin-producing cells to help the body adapt more quickly to schedule disruptions like jet lag and shift work. Key takeaways:
Researchers developed an implantable cell therapy that continuously produces leptin to accelerate circadian realignment. In preclinical models, the therapy reduced the time required to adjust to schedule shifts mimicking jet lag and shift work. The encapsulated cel…
This story is only covered by news sources that have yet to be evaluated by the independent media monitoring agencies we use to assess the quality and reliability of news outlets on our platform. Learn more here.